Beijing Beilu Pharmaceutical Cash Flow-to-Debt Ratio
Beijing Beilu Pharmaceutical cash flow-to-debt ratio. Beijing Beilu Pharmaceutical (300016) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥74.66 Million could theoretically repay 0% of its total liabilities (CN¥852.80 Million) in one year. Check Beijing Beilu Pharmaceutical total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Beilu Pharmaceutical (2006–2024)
Cash flow-to-debt ratio of Beijing Beilu Pharmaceutical from 2006 to 2024. Historical debt coverage capacity for Beijing Beilu Pharmaceutical across 19 annual periods. Check 300016 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Beijing Beilu Pharmaceutical Cash Flow-to-Debt Ratio by Year (2006–2024)
Beijing Beilu Pharmaceutical cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Beijing Beilu Pharmaceutical. For the full cash flow conversion analysis, see 300016 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥163.02 Million | CN¥1.15 Billion | ▲ +150.9% |
| 2023 | 0.06x | CN¥58.46 Million | CN¥1.03 Billion | ▼ -60.5% |
| 2022 | 0.14x | CN¥127.81 Million | CN¥892.27 Million | ▲ +7.8% |
| 2021 | 0.13x | CN¥108.73 Million | CN¥818.22 Million | ▼ -27.9% |
| 2020 | 0.18x | CN¥176.00 Million | CN¥955.50 Million | ▼ -79.6% |
| 2019 | 0.90x | CN¥156.81 Million | CN¥173.31 Million | ▼ -57.3% |
| 2018 | 2.12x | CN¥175.75 Million | CN¥82.93 Million | ▲ +4.8% |
| 2017 | 2.02x | CN¥144.92 Million | CN¥71.65 Million | ▲ +44.5% |
| 2016 | 1.40x | CN¥76.17 Million | CN¥54.40 Million | ▲ +103.3% |
| 2015 | 0.69x | CN¥80.85 Million | CN¥117.39 Million | ▲ +293.7% |
| 2014 | 0.17x | CN¥42.11 Million | CN¥240.67 Million | ▼ -74.1% |
| 2013 | 0.68x | CN¥41.37 Million | CN¥61.16 Million | ▲ +76.5% |
| 2012 | 0.38x | CN¥22.86 Million | CN¥59.64 Million | ▼ -72.2% |
| 2011 | 1.38x | CN¥45.73 Million | CN¥33.19 Million | ▼ -72.5% |
| 2010 | 5.01x | CN¥37.51 Million | CN¥7.49 Million | ▲ +52.3% |
| 2009 | 3.29x | CN¥57.91 Million | CN¥17.60 Million | ▲ +1932.4% |
| 2008 | -0.18x | CN¥-4.76 Million | CN¥26.52 Million | ▼ -175.1% |
| 2007 | 0.24x | CN¥12.28 Million | CN¥51.36 Million | ▼ -34.2% |
| 2006 | 0.36x | CN¥19.65 Million | CN¥54.10 Million | — |